NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









National Center for Advancing Translational Sciences

National Center for Advancing Translational Sciences

Bethesda, Marylandncats.nih.gov

Overview

The National Center for Advancing Translational Sciences (NCATS) is one of 27 institutes and centers of the U.S. National Institutes of Health (NIH). Its mission is to transform scientific discoveries into new treatments and cures for disease that can be delivered faster to patients. The center focuses on what is common across diseases and the translational process, studying it as a scientific and operational problem. NCATS provides funding and resources through grants, prize competitions, and collaborations with the public and private sectors to reduce, remove, or bypass bottlenecks in the translational research pipeline.

Portfolio Companies

41

Investments

National Center for Advancing Translational Sciences investments
CompanyDateStageLead
Neucore BioSep 2025GrantCo-investor
CILA TherapeuticsAug 2025GrantCo-investor
SimplusDxJul 2025GrantCo-investor
Phrase HealthAug 2024GrantCo-investor
Rejuvenation TechnologiesAug 2024GrantCo-investor

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersBethesda, Maryland
Year FoundedN/A

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.